Clinical applications of in vivo magnetic resonance spectroscopy in oncology. (26th October 2018)

• Record Type: Journal Article
• Authors: Payne, Geoffrey S
• Is Part Of: Physics in medicine & biology. Volume 63:Number 21(2018:Nov.)
• Publication Date: 2018-10-26
• Subjects: magnetic resonance spectroscopy -- mrs -- oncology -- cancer -- review; Biophysics -- Periodicals; Medical physics -- Periodicals; 610.153
• DOI: 10.1088/1361-6560/aae61e
• Languages: English
• ISSNs: 0031-9155

Abstract

Abstract: Magnetic resonance spectroscopy (MRS) can be performed in vivo using commercial MRI systems to obtain biochemical information about tissues and cancers. Applications in brain, prostate and breast aid lesion detection and characterisation (differential diagnosis), treatment planning and response assessment. Multi-centre clinical trials have been performed in all these tissues. Single centre studies have been performed in many other tissues including cervix, uterus, musculoskeletal and liver. While generally MRS is used to study endogenous metabolites it has also been used in drug studies, for example those that include 19 F as part of their structure. Recently the hyperpolarisation of compounds enriched with 13 C such as [1- 13 C] pyruvate has been demonstrated in animal models and now in preliminary clinical studies, permitting the monitoring of biochemical processes with unprecedented sensitivity. This review briefly introduces the underlying methods and then discusses the current status of these applications.